The effect of somatostatin analogs and acromegaly on the upper gastrointestinal system.

Serdar SahinTevhide Betul IcliEmre DurcanCem SuluHande Mefkure OzkayaAli Ibrahim HatemiPinar Kadioglu

Published in: Pituitary (2020)

The study showed that octreotide LAR treatment could be a risk factor in addition to known factors for the development of gastritis in patients with acromegaly.

Keyphrases

risk factors
helicobacter pylori
neuroendocrine tumors
helicobacter pylori infection
growth hormone
combination therapy
molecular dynamics simulations